Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1715183rdf:typepubmed:Citationlld:pubmed
pubmed-article:1715183lifeskim:mentionsumls-concept:C0025936lld:lifeskim
pubmed-article:1715183lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:1715183lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:1715183lifeskim:mentionsumls-concept:C0221099lld:lifeskim
pubmed-article:1715183lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:1715183lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:1715183lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:1715183pubmed:issue4lld:pubmed
pubmed-article:1715183pubmed:dateCreated1991-9-27lld:pubmed
pubmed-article:1715183pubmed:abstractTextTransgenic mice carrying the proto-oncogene c-fos under the control of H-2Kb promoter (c-fos mice) were generated from (C57BL/6 x SJL)F2 mice. One line was backcrossed with C57BL/6 mice for 10 generations. These semi-congenic c-fos mice express exogenous c-fos RNA in their hematopoietic tissues. The following immunological states are apparent. (i) Titers of serum IgM, IgG, and IgA of naive c-fos were within the control range. (ii) These mice could not produce primary IgG antibody specific for immunized antigen. (iii) Production of primary IgM and IgA antibody to the antigen was within the control range. (iv) There were no IgG memory B cells generated in the spleens of c-fos mice. (v) Activities of antigen-presenting cells and carrier-specific helper T cells from c-fos mice were normal. These findings strongly suggest that the immune abnormality of c-fos mice is in limiting B cell function to the production of IgG to immunized antigens.lld:pubmed
pubmed-article:1715183pubmed:languageenglld:pubmed
pubmed-article:1715183pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1715183pubmed:citationSubsetIMlld:pubmed
pubmed-article:1715183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1715183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1715183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1715183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1715183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1715183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1715183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1715183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1715183pubmed:statusMEDLINElld:pubmed
pubmed-article:1715183pubmed:monthAprlld:pubmed
pubmed-article:1715183pubmed:issn0953-8178lld:pubmed
pubmed-article:1715183pubmed:authorpubmed-author:HatanoMMlld:pubmed
pubmed-article:1715183pubmed:authorpubmed-author:TakaiYYlld:pubmed
pubmed-article:1715183pubmed:authorpubmed-author:SakaiNNlld:pubmed
pubmed-article:1715183pubmed:authorpubmed-author:TokuhisaTTlld:pubmed
pubmed-article:1715183pubmed:authorpubmed-author:KoizumiTTlld:pubmed
pubmed-article:1715183pubmed:authorpubmed-author:RütherUUlld:pubmed
pubmed-article:1715183pubmed:authorpubmed-author:HaniokaKKlld:pubmed
pubmed-article:1715183pubmed:issnTypePrintlld:pubmed
pubmed-article:1715183pubmed:volume3lld:pubmed
pubmed-article:1715183pubmed:ownerNLMlld:pubmed
pubmed-article:1715183pubmed:authorsCompleteYlld:pubmed
pubmed-article:1715183pubmed:pagination369-75lld:pubmed
pubmed-article:1715183pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:meshHeadingpubmed-meshheading:1715183-...lld:pubmed
pubmed-article:1715183pubmed:year1991lld:pubmed
pubmed-article:1715183pubmed:articleTitleIgG response is impaired in H2-c-fos transgenic mice.lld:pubmed
pubmed-article:1715183pubmed:affiliationDepartment of Immunology, ICMR, Kobe, Japan.lld:pubmed
pubmed-article:1715183pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1715183pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1715183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1715183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1715183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1715183lld:pubmed